AH-D peptide 

AH-D peptide is an antiviral peptide that selectively disrupts membrane structures within the size range of exosomes, inducing T-EXO depletion and enhancing cancer immunotherapy^[1].

3283.75

C₁₅₄H₂₂₈N₃₈O₄₀S

d-{Ser-Gly-Ser-Trp-Leu-Arg-Asp-Val-Trp-Asp-Trp-Ile-Cys-Thr-Val-Leu-Thr-Asp-Phe-Lys-Thr-Trp-Leu-Gln-Ser-Lys-Leu-NH2}

d-{SGSWLRDVWDWICTVLTDFKTWLQSKL-NH2}

O=C(NCC(N[C@H](CO)C(N[C@H](CC1=CNC2=CC=CC=C12)C(N[C@H](CC(C)C)C(N[C@H](CCCNC(N)=N)C(N[C@H](CC(O)=O)C(N[C@H](C(C)C)C(N[C@H](CC3=CNC4=CC=CC=C34)C(N[C@H](CC(O)=O)C(N[C@H](CC5=CNC6=CC=CC=C56)C(N[C@H]([C@H](C)CC)C(N[C@H](CS)C(N[C@H]([C@@H](O)C)C(N[C@H](C(C)C)C(N[C@H](CC(C)C)C(N[C@H]([C@@H](O)C)C(N[C@H](CC(O)=O)C(N[C@H](CC7=CC=CC=C7)C(N[C@H](CCCCN)C(N[C@H]([C@@H](O)C)C(N[C@H](CC8=CNC9=CC=CC=C89)C(N[C@H](CC(C)C)C(N[C@H](CCC(N)=O)C(N[C@H](CO)C(N[C@H](CCCCN)C(N[C@H](CC(C)C)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](CO)N

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Sol Shin, et al. Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy. Nat Mater. 2023 May;22(5):656-665.